COVID-19 in lung cancer patients receiving ALK/ROS1 inhibitors
Author:
Funder
Roche
BMS
AstraZeneca
Pfizer
Eli Lilly
Novartis
MSD,
Boehringer Ingelheim
Otsuka
Takeda
Pierre Fabre
Publisher
Elsevier BV
Subject
Cancer Research,Oncology
Reference7 articles.
1. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia;Li;N Engl J Med,2020
2. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China;Liang;Lancet Oncol,2020
3. Q&A on COVID-19 | ESMO. https://www.esmo.org/newsroom/covid-19-and-cancer/q-a-on-covid-19. Accessed April 2, 2020.
4. Cancer, COVID-19 and the precautionary principle: prioritizing treatment during a global pandemic;Hanna;Nat Rev Clin Oncol,2020
5. Profiling early humoral response to diagnose novel coronavirus disease (COVID-19);Guo;Clin Infect Dis,2020
Cited by 30 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. EGFR-TKIs Combined with Allogeneic CD8+ NKT Cell Immunotherapy to Treat Patients with Advanced EGFR-Mutated Lung Cancer;Technology in Cancer Research & Treatment;2024-01
2. Cancer management during the COVID-19 world pandemic;Cancer Immunology, Immunotherapy;2023-08-29
3. Serine-arginine protein kinases and their targets in viral infection and their inhibition;Cellular and Molecular Life Sciences;2023-05-17
4. COVID-19 vaccination uptake and safety profile among germline BRCA1 and BRCA2 pathogenic variant carriers in Singapore;Hereditary Cancer in Clinical Practice;2023-04-12
5. Areas of Uncertainty in SARS-CoV-2 Vaccination for Cancer Patients;Vaccines;2022-12-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3